115 related articles for article (PubMed ID: 8960826)
21. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
Strandberg K; Svensson PJ; Ohlin AK
Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
[TBL] [Abstract][Full Text] [Related]
22. Decreased Activity of the Protein C Anticoagulant Pathway in the Early Hours of Paroxysmal Atrial Fibrillation.
Negreva M; Georgiev S; Vitlianova K
Clin Appl Thromb Hemost; 2017 Oct; 23(7):793-799. PubMed ID: 27313201
[TBL] [Abstract][Full Text] [Related]
23. Prospective study on plasma clotting parameters in diabetic children--no evidence for specific changes in coagulation system.
Zeitler P; Thiede A; Müller HL
Exp Clin Endocrinol Diabetes; 2001; 109(3):146-50. PubMed ID: 11409296
[TBL] [Abstract][Full Text] [Related]
24. Haemostasis, cytoadhesive molecules (sE-selectin and sICAM-1) and inflammatory markers in non-insulin dependent diabetes mellitus (NIDDM).
Kvasnicka J; Skrha J; Perusicová J; Kvasnicka T; Marková M; Umlaufová A; Pecen L
Sb Lek; 1998; 99(2):97-101. PubMed ID: 10536488
[TBL] [Abstract][Full Text] [Related]
25. Prothrombotic and antithrombotic factors are elevated in patients with type 1 diabetes complicated by microalbuminuria.
Lee P; Jenkins A; Bourke C; Santamaria J; Paton C; Janus E; Best J
Diabet Med; 1993 Mar; 10(2):122-8. PubMed ID: 8458188
[TBL] [Abstract][Full Text] [Related]
26. Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment.
Albertini JP; Valensi P; Lormeau B; Aurousseau MH; Ferrière F; Attali JR; Gattegno L
Diabetes Care; 1998 Jun; 21(6):1008-13. PubMed ID: 9614623
[TBL] [Abstract][Full Text] [Related]
27. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?
Brohi K; Cohen MJ; Ganter MT; Matthay MA; Mackersie RC; Pittet JF
Ann Surg; 2007 May; 245(5):812-8. PubMed ID: 17457176
[TBL] [Abstract][Full Text] [Related]
28. Effects of heparin treatment on hemostatic abnormalities in obese non-insulin-dependent diabetic patients.
Avellone G; di Garbo V; Cordova R; Rotolo G; Raneli G; de Simone R; Bompiani G
Metabolism; 1997 Aug; 46(8):930-4. PubMed ID: 9258277
[TBL] [Abstract][Full Text] [Related]
29. Post-meal coagulation activation in diabetes mellitus: the effect of acarbose.
Ceriello A; Taboga C; Tonutti L; Giacomello R; Stel L; Motz E; Pirisi M
Diabetologia; 1996 Apr; 39(4):469-73. PubMed ID: 8777997
[TBL] [Abstract][Full Text] [Related]
30. Low plasma activated protein C-protein C inhibitor complex concentration is associated with vascular access failure in hemodialysis patients.
Bakoush O; Ohlin AK; Strandberg K; Kurkus J
Nephron Clin Pract; 2008; 110(3):c151-7. PubMed ID: 18953177
[TBL] [Abstract][Full Text] [Related]
31. Coagulation markers predicting cardiac transplant rejection.
Segal JB; Kasper EK; Rohde C; Bray PF; Baldwin WM; Resar JR; Hruban RH; Kickler TS
Transplantation; 2001 Jul; 72(2):233-7. PubMed ID: 11477344
[TBL] [Abstract][Full Text] [Related]
32. Inverse correlation between activated protein C generation and carotid atherosclerosis in Type 2 diabetic patients.
Matsumoto K; Yano Y; Gabazza EC; Araki R; Bruno NE; Suematsu M; Akatsuka H; Katsuki A; Taguchi O; Adachi Y; Sumida Y
Diabet Med; 2007 Dec; 24(12):1322-8. PubMed ID: 17971179
[TBL] [Abstract][Full Text] [Related]
33. No effect of the prothrombin G20210A mutation on protein C activation in a large kindred with type I protein C deficiency.
Vossen CY; Strandberg K; Stenflo J; Rosendaal FR; Callas PW; Long GL; Bovill EG
Blood Coagul Fibrinolysis; 2004 Oct; 15(7):573-6. PubMed ID: 15389124
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease.
Woodward M; Lowe GD; Rumley A; Tunstall-Pedoe H; Philippou H; Lane DA; Morrison CE
Br J Haematol; 1997 Jun; 97(4):785-97. PubMed ID: 9217177
[TBL] [Abstract][Full Text] [Related]
35. Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma.
Ohlin AK; Larsson K; Hansson M
J Thromb Haemost; 2005 May; 3(5):976-82. PubMed ID: 15869594
[TBL] [Abstract][Full Text] [Related]
36. Coagulopathy after successful cardiopulmonary resuscitation following cardiac arrest: implication of the protein C anticoagulant pathway.
Adrie C; Monchi M; Laurent I; Um S; Yan SB; Thuong M; Cariou A; Charpentier J; Dhainaut JF
J Am Coll Cardiol; 2005 Jul; 46(1):21-8. PubMed ID: 15992630
[TBL] [Abstract][Full Text] [Related]
37. Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria.
Collier A; Rumley A; Rumley AG; Paterson JR; Leach JP; Lowe GD; Small M
Diabetes; 1992 Aug; 41(8):909-13. PubMed ID: 1628764
[TBL] [Abstract][Full Text] [Related]
38. Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1.
Aso Y; Matsumoto S; Fujiwara Y; Tayama K; Inukai T; Takemura Y
Metabolism; 2002 Apr; 51(4):471-6. PubMed ID: 11912556
[TBL] [Abstract][Full Text] [Related]
39. Markers of platelet, endothelial cell and blood coagulation activation in leprosy patients with antiphospholipid antibodies.
Martinuzzo ME; de Larrañaga GF; Forastiero RR; Pelegri Y; Fariña MH; Alonso BS; Kordich LC; Carreras LO
Clin Exp Rheumatol; 2002; 20(4):477-83. PubMed ID: 12175102
[TBL] [Abstract][Full Text] [Related]
40. Changes in coagulation and hemodynamics during pregnancy: a prospective longitudinal study of 58 cases.
Hui C; Lili M; Libin C; Rui Z; Fang G; Ling G; Jianping Z
Arch Gynecol Obstet; 2012 May; 285(5):1231-6. PubMed ID: 22083312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
